$KALA
KALA BIO, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Arlington, MA
KALA chart
What traders are saying about $KALA
Latest postsKALA BIO, Inc. news
- Live KALA BIO (KALA) Technical Analysis
Traders Union ·
- KALA BIO, Inc. Estimates – NASDAQ:KALA
TradingView ·
- KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Yahoo Finance ·
- Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
Yahoo Finance ·
- KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
Yahoo Finance ·
- Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests
investorshub.advfn.com ·
- Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
Yahoo Finance ·
- Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership
investorshub.advfn.com ·
- Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
Yahoo Finance ·
- KALA BIO Announces Reverse Stock Split
Yahoo Finance ·
- Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
Yahoo Finance ·
- Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
Yahoo Finance ·
KALA BIO, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$27.0M | -$38.5M | -$42.2M | -$44.8M |
| Diluted EPS | $-3.31 | $-10.15 | $-17.35 | $-29.48 |
| Total assets (year end) | $9.5M | $55.5M | $55.9M | $86.8M |
| Cash and equivalents (year end) | $7.6M | $51.2M | $50.9M | $70.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About KALA BIO, Inc.
- Ticker
- KALA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Arlington, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1479419
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Frequently asked questions
What exchange is KALA BIO, Inc. listed on?
KALA BIO, Inc. trades on the Nasdaq under the ticker symbol KALA.
What industry is KALA BIO, Inc. in?
KALA BIO, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is KALA BIO, Inc. headquartered?
KALA BIO, Inc.'s business address on file with the SEC is in Arlington, MA.
When does KALA BIO, Inc.'s fiscal year end?
KALA BIO, Inc.'s fiscal year ends on December 31.
How much revenue did KALA BIO, Inc. report?
KALA BIO, Inc. reported $0 in revenue for calendar year 2017, according to its SEC filings.